VF
NVIV

Virtu Financial’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Virtu Financial’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,040
Closed -$58K – 2497
2021
Q4 		$58K Buy
+5,040
New +$72.3K 0.01% 1308
2021
Q3 		– Sell
-1,794
Closed -$33K – 2363
2021
Q2 		$33K Sell
1,794
-3,792
-68% -$72.2K ﹤0.01% 1382
2021
Q1 		$139K Buy
+5,586
New +$167K 0.01% 1212
2018
Q2 		– Sell
-1
Closed -$6K – 2810
2018
Q1 		$6K Sell
1
-1
-50% -$11.2K ﹤0.01% 1867
2017
Q4 		$32K Buy
2
+1
+100% +$23.1K ﹤0.01% 2150
2017
Q3 		$22K Buy
+1
New +$30.7K ﹤0.01% 2340

Other funds holding NVIV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return

Virtu Financial's NVIV Position: Q1 2022 in Review

Virtu Financial sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q1 2022, closing a stake of 5,040 shares — an estimated $58K sold.

Virtu Financial first reported a position in NVIV in Q3 2017 and held it in 6 quarters. The position peaked at $139K in Q1 2021. 16 funds tracked by Wall St. Rank hold NVIV as of Q1 2022.

  • Virtu Financial reported no remaining InVivo Therapeutics Holdings Corp position as of Q1 2022 after selling out during the quarter.
  • Virtu Financial sold 5,040 InVivo Therapeutics Holdings Corp shares in Q1 2022, an estimated $58K.
  • Virtu Financial first reported a position in InVivo Therapeutics Holdings Corp in Q3 2017 and held it in 6 quarters.
  • Virtu Financial's InVivo Therapeutics Holdings Corp position peaked at $139K in Q1 2021.
  • 16 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q1 2022.

Based on Virtu Financial's 13F filing for Q1 2022, filed 17 May 2022.